Search

Search Constraints

You searched for: Author/Creator Peris, K.

Search Results

2. A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis. (17th February 2022)

3. A 52‐week update of a multicentre real‐life experience on effectiveness and safety of risankizumab in psoriasis. (19th September 2021)

6. A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16‐week real‐life experience during the COVID‐19 pandemic. (8th November 2020)

7. A multicentre study of naevus‐associated melanoma vs. de novo melanoma, tumour thickness and body site differences. (1st April 2021)

8. A multicentre study of naevus‐associated melanoma vs. de novo melanoma, tumour thickness and body site differences. (1st July 2021)